SALT Holding Corp’s AstraZeneca AZN Stock Holding History

SALT Holding Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7M	Hold	93,250	–	–	9.37%	3
2026 Q1	$18.4M	Hold	93,250	–	–	11.11%	3
2025 Q4	$17.1M	Buy	93,250 +84,650	+984%	+$14.8M	13.29%	3
2025 Q3	$1.32M	Buy	+8,600	New	+$1.3M	1.23%	9
2025 Q2	–	Sell	-7,600	Closed	-$1.12M	–	9
2025 Q1	$1.12M	Hold	7,600	–	–	1.04%	7
2024 Q4	$996K	Buy	+7,600	New	+$1.06M	1.22%	8

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SALT Holding Corp's AZN Position: Q2 2026 in Review

SALT Holding Corp held its AstraZeneca (AZN) position steady in Q2 2026 at 93,250 shares worth $17.7M. The position accounts for 9.37% of the portfolio, ranked #3.

SALT Holding Corp first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.4M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

SALT Holding Corp held 93,250 shares of AstraZeneca worth $17.7M as of Q2 2026.
SALT Holding Corp left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 9.37% of SALT Holding Corp's portfolio in Q2 2026, its #3 holding.
SALT Holding Corp first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
SALT Holding Corp's AstraZeneca position peaked at $18.4M in Q1 2026.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SALT Holding Corp's 13F filing for Q2 2026, filed 14 Aug 2026.